At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 128 target
Drug / intervention
ProbioStick +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double Blind Placebo Controlled Study on the Effects of a Probiotic on Autonomic and Psychological Stress Responses in Volunteers
In Brief
A Phase 3 clinical trial evaluating ProbioStick and Placebo for Stress, Psychological. Completed, enrolled 128 participants across 1 site.
Detailed Summary
The purpose of this study is to investigate the effects of a probiotic blend on qualitative (subjective interviews and self-reporting) and quantitative (changes in brain activity, heart rate, cortisol, and reactivity) measures of stress in healthy undergraduate students.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStress, Psychological
CountriesCanada
CollaboratorsLallemand Health Solutions
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartSep 2015
Primary CompletionAug 2017
TodayJul 2026
First PostedApr 15, 2015
Enrollment StartSep 1, 2015
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.2 years ago
Interventions
ProbioStickdietary
One sachet daily, without or without meals (3 x 10\^9 CFU per sachet) (Lactobacillus helveticus R0052 and Bifidobacterium longum subsp. longum R0175)
Placeboother
One sachet daily, without or without meals (0 CFU per sachet)